Skip to main content
. Author manuscript; available in PMC: 2023 Nov 1.
Published in final edited form as: Alzheimers Dement. 2022 Feb 1;18(11):2199–2208. doi: 10.1002/alz.12519

Table 1:

Baseline demographics and medical history.

MBI−
(N=8607)
MBI+
(N=2765)
Test statistic
(t-stat or X2 stat)
p-value
Demographics (mean (SD) or N(%))
Age 70.6 (10.4) 70.1 (10.3) 2.2 .03
MMSE 29.0 (1.4) 28.8 (1.5) 3.8 <.001
Education (yrs) 15.9 (2.9) 15.6 (3.1) 4.8 <.001
Sex (male) 2828 (33%) 1092 (40%) 40.8 <.001
Medications (use versus no use) N(%))
Anxiolytic 834 (10%) 434 (16%) 76.2 <.001
Antidepressant 1264 (15%) 818 (30%) 310.6 <.001
Antipsychotic 34 (.4%) 27 (1%) 13.3 <.001
Medical Conditions (presence versus absence) (N(%))
Diabetes 840 (10%) 333 (12%) 11.9 .001
Hypercholesterolemia 3801 (46%) 1353 (51%) 20.9 <.001
Hypertension 3736 (45%) 1297 (48%) 12.2 <.001
Heart attack 58 (.7%) 24 (1%) 1.2 .28
Atrial Fibrillation 333 (4%) 142 (5%) 8.3 .004
Stroke 38 (.4%) 18 (.7%) 1.9 .16
TIA 88 (1%) 28 (1%) 0 .99
Health Behaviours (mean (SD) or N(%))
Smoking (years) 8.7 (13.8) 10.1 (15.0) −4.5 <.001
Alcohol abuse (past or present) 29 (.3%) 20 (.8%) 7.8 .01
Other Risk Factors
APOE4 allele (presence versus absence) 2339 (31%) 767 (32%) 1.6 .20
HHS Vulnerability Disclosure